** Shares of the health tech co MDVL.O fall as much as
31.03% to $5.18 premarket
** Stock tops pct losers among Nasdaq stocks trading
premarket
** Co lowered its 2021 net revenue outlook from the prior
range of between $27 to $31 million to at least $21 million
urn:newsml:reuters.com:*:nBwbTJ9Ksa
** Co says it identified 10 clinics that do not meet
expectations and have decided to exit these sites prior to 2021
** Co's Q2 Pharmacy Technology sales decreased 10% to $0.5
million
** Due to lingering COVID-19 uncertainties, co has
encountered unanticipated headwinds with the timing of Boards of
Pharmacy regulatory approvals -MDVL
** Stock down ~50% YTD, as of last close
(Reporting by Rithika Krishna in Bengaluru)
((Rithika.Krishna@thomsonreuters.com;))